Bon Natural Life stock rises on new $22 million distribution deal

Published 21/07/2025, 14:52
© Reuters.

Investing.com -- Bon Natural Life Ltd (NASDAQ:BON) stock gained 4.6% after the bio-ingredient solutions provider announced a non-exclusive sales distribution agreement with Beijing Huahai Keyuan Technology Co. Ltd. for its natural weight loss product line.

The 36-month agreement, valued at $22 million, will see Huahai Keyuan distribute BON’s weight management products across China and Southeast Asia. The products feature a "prebiotics + postbiotics" compound formula that the company describes as an innovative approach to weight loss that doesn’t require restrictive dieting.

"As a global participant in ’prebiotics + postbiotics’ health solutions, we’re thrilled to introduce our new line of advanced, sustained-action weight management supplements," said Yongwei Hu, Chairman and CEO of BON. "We are excited to partner with Huahai Keyuan. As a leading health enterprise in China, Huahai Keyuan specializes in marketing original health products and has an impressive track record in expanding markets and building strong brands."

The partnership aims to help BON enter China’s weight management market, which the company characterized as large and fast-growing. Huahai Keyuan will sell and distribute BON’s natural weight loss products throughout the region during the term of the agreement.

Bon Natural Life provides bio-ingredient solutions for the natural health and personal care industries.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.